[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Investigation Report on China Thrombin Market, 2010-2019

June 2015 | 35 pages | ID: I9FEACC85AFEN
China Research and Intelligence Co., Ltd.

US$ 2,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Description

Anticoagulant, including various products, is mainly used to prevent blood clotting. It will also be used when patients need to connect to some medical instruments or receive blood transfusions or when their blood needs to be sent for testing. Through the use of anticoagulant, diseases caused by blood clots like deep venous thrombosis, pulmonary embolism, myocardial infarction and stroke can be avoided.

With the ageing population and the increased incidence of cardiovascular diseases, current gold standard anticoagulants have become unable to satisfy the treatment demand. It is inevitable for improved drugs to come into the market. Warfarin and heparin which have monopolized the anticoagulant market for over half a century will gradually be replaced by the new generation of direct thrombin inhibitor and Xa factor inhibitor and finally fade out.

The representative varieties of thrombin are as follows: hirudin, recombinant hirudin, bivalirudin, argatroban and dabigatran etexilate. Direct thrombin inhibitor brought in a sales value of USD 2.4 billion in 2013, ranking third among anti-clotting drugs. And it occupied 10.4% of the total sales value of anti-clotting drugs while dabigatran etexilate accounted for 73.6% of the sum. According to CRI’s survey, the sales value of thrombin in China rose from CNY 13 million in 2005 to CNY 20.77 million in 2014 with CAGR during this period reaching about 5.6%. Currently, major manufacturers of thrombin in the Chinese market are Changchun Guoao Pharmaceutical Co., Ltd, Biochemical Pharmaceutical Factory of Zhuhai S. E. Z., Hunan Yige Pharmaceutical Co., Ltd, Hacon Pharma and Wuxi Kaifu Pharmaceutical Co., Ltd.

With the change of life styles and ageing population, the incidence of cardiovascular disease is expected to keep increasing in the next few years in China, driving the market size of thrombin to expand further.

Readers can get at least the following information from this report:
  • market size of thrombin in China
  • competitive landscape of thrombin in Chinese market
  • price of thrombin made by different enterprises in China
  • market outlook of thrombin in China
The author suggests the following groups of people purchase this report:
  • manufacturers of anticoagulants
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service
1 RELATED CONCEPTS OF THROMBIN

1.1 Indication
1.2 Sales Status in Global Market

2 MARKET PROFILE OF THROMBIN IN CHINA

2.1 Patent and Approval Status of Thrombin in China
2.2 Major Manufacturers
2.3 Market Size

3 SURVEY ON SALES STATUS OF THROMBIN IN CHINA, 2010-2014

3.1 Sales Value
  3.1.1 Overall Sales Value
  3.1.2 Sales Value by Regions
3.2 Sales Volume
  3.2.1 Overall Sales Volume
  3.2.2 Sales Volume by Regions

4 SURVEY ON MARKET SHARE OF MAJOR MANUFACTURERS OF THROMBIN IN CHINA, 2010-2014

4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 SURVEY ON DOSAGE FORMS OF THROMBIN IN CHINA, 2010-2014

5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 REFERENCE PRICE OF THROMBIN IN CHINESE HOSPITALS IN 2014

6.1 Shanghai Livzon Pharmaceutical Co., Ltd
6.2 Shanghai No.1 Biochemical & Pharmaceutical Co., Ltd
6.3 Nanjing Xinbai Pharmaceuitcal Co., Ltd
6.4 Wuxi Kaifu Pharmaceutical Co., Ltd (Trade Name: Kaitian)
6.5 Hacon Pharma
6.6 Wuhan Hiteck Biological Pharma Co., Ltd
6.7 Hunan Yige Pharmaceutical Co., Ltd
6.8 Biochemical Pharmaceutical Factory of Zhuhai S. E. Z.
6.9 Changchun Guoao Pharmaceutical Co., Ltd (Trade Name: Bangting)

7 MAJOR MANUFACTURERS OF THROMBIN IN CHINESE MARKET, 2010-2014

7.1 Changchun Guoao Pharmaceutical Co., Ltd
7.2 Biochemical Pharmaceutical Factory of Zhuhai S. E. Z.
7.3 Hunan Yige Pharmaceutical Co., Ltd
7.4 Hacon Pharma
7.5 Wuxi Kaifu Pharmaceutical Co., Ltd

8 MARKET OUTLOOK OF THROMBIN IN CHINA, 2015-2019

8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

TABLE OF SELECTED CHARTS

Chart Approval Information of Thrombin in China
Chart Sales Status of Thrombin in China, 2010-2014
Chart Sales Value of Thrombin in China, 2010-2014
Chart Sales Value of Thrombin in Some Regions in China, 2010-2014
Chart Sales Volume of Thrombin in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Thrombin for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Thrombin Made by Changchun Guoao, 2010-2014
Chart Sales Value and Market Share of Thrombin Made by Hacon in China, 2010-2014
Chart Sales Value and Market Share of Thrombin Made by Hunan Yige in China, 2010-2014
Chart Sales Value and Market Share of Thrombin Made by Biochemical Pharmaceutical Factory of Zhuhai S. E. Z. in China, 2010-2014
Chart Sales Value and Market Share of Thrombin Made by Wuxi Kaifu Pharmaceutical in China, 2010-2014
Chart Price of Thrombin Made by Shanghai Livzon Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Thrombin Made by Shanghai No.1 Biochemical & Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Thrombin Made by Nanjing Xinbai Pharmaceuitcal Co., Ltd in Some Chinese Cities in 2014
Chart Price of Thrombin Made by Wuxi Kaifu Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Thrombin Made by Hacon Pharma in Some Chinese Cities in 2014
Chart Price of Thrombin Made by Wuhan Hiteck Biological Pharma Co., Ltd in Some Chinese Cities in 2014
Chart Price of Thrombin Made by Hunan Yige Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Thrombin Made by Biochemical Pharmaceutical Factory of Zhuhai S. E. Z. in Some Chinese Cities in 2014
Chart Price of Thrombin Made by Changchun Guoao Pharmaceutical Co., Ltd in Some Chinese Cities in 2014


More Publications